Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/6841
Email LibraryRMU.DOH@nt.gov.au to ask for this document in a different format
Title: Nontuberculous mycobacterial disease in northern Australia: a case series and review of the literature.
Authors: O'Brien, D P
Currie, B J
Krause, V L
Citation: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000-10; 31(4): 958-67
Abstract: We performed a retrospective/prospective review of all cases of disease due to nontuberculous mycobacteria (NTM) reported in the Northern Territory, Australia, during the period 1989-1997. Fifty-eight cases were reported, with an average yearly incidence of 3.9 cases per 100,000 persons. The number increased significantly for the second half of the study period (39 vs. 19 cases; P<.02). The yearly incidence of pulmonary Mycobacterium avium/Mycobacterium intracellulare complex (MAC) disease not associated with human immunodeficiency virus (HIV) infection was 2.1 cases per 100,000 population. MAC was the most common isolate (78%) and pulmonary disease the most frequent clinical presentation (62%). Disease due to NTM or MAC was not found more commonly in rural areas. Significant risks for non-HIV-associated pulmonary MAC disease included male sex (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.0-4.5) and age >50 years (OR, 26.5; 95% CI, 10.9-67.3), but aboriginal people appeared underrepresented (OR, 0.77; 95% CI, 0.30-1.87). Mycobacterium tuberculosis was almost 5 times more likely than NTM to be the cause of non-HIV-associated mycobacterial pulmonary disease (153 vs. 32 cases; OR, 4.79; 95% CI, 3.22-7.14). Mycobacterial lymphadenitis in aboriginal children was more likely to be tuberculous than nontuberculous (OR, 6.5; 95% CI, 1.4-41.7), but not in nonaboriginal children (OR, 1.0). With treatment, 66% of the cases of non-HIV-associated pulmonary MAC disease had favorable outcomes, and 7% of patients had progressive fatal disease. Outcomes of therapy for lymphadenitis and skin/soft-tissue disease were excellent, but those of HIV-associated disseminated MAC disease were poor.
Click to open PubMed article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/11049777
Click to open Pubmed Article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/11049777
Journal title: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publication Date: 2000-10
ISSN: 1058-4838
Type: Journal Article
Review
URI: https://hdl.handle.net/10137/6841
DOI: 10.1086/318136
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
File SizeFormat 
Standard Drug List PHC Remote Master Document.xlsx130.74 kBMicrosoft Excel XMLView/Open


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.